INTRODUCTION
Esophageal tumours develop inside the circumference of the lumen and are very difficult to treat for two reasons. They are sometimes sector-based and the tumour thickness can vary significantly from one point to another. Furthermore, most occurrences of this type of cancer are not amenable to curative resection because of the extent of the tumour at diagnosis and the presence of a comorbid condition. Radiochemotherapy has not demonstrated any survival advantage so far. Photocoagulation by laser is used sometimes (De Palma et al. 1999; Sharma et al. 1999 ), but it is relatively expensive and demanding, because tissue destruction is superficial and several sessions are generally needed to achieve symptomatic improvement. Thus, for this form of cancer, a minimally invasive local treatment, leading to an immediate, in-depth and complete destruction of the targeted tissue, should be envisaged as both curative and palliative strategy for a large number of patients.
Among the interstitial heating modalities for therapeutic thermal ablation, ultrasound presents two major advantages. Ultrasound penetrates deep into tissues allowing some extent of the coagulated volume (ter Haar and Robertson, 1993) . Treatments by ultrasound are welldelimited; damages to surrounding tissues are minimal. In the past, high intensity ultrasound has proved to be highly efficient, both experimentally and clinically, in inducing homogeneous and reproducible tumour destruction by thermal coagulation necrosis (Fry and Johnson 1978 , Chapelon et al. 1999 , Gelet et al. 2000 . World-wide clinical applications of focused ultrasound surgery (FUS) include the treatment of glaucoma (Burgess et al., 1986) , benign prostatic hyperplasia (BPH) (Madersbacher et al., 1995 Uchida et al., 1998 and treatment of localised prostatic cancer of the prostate (Chapelon et al. 1992) bladder (Vallancian et al., 1996) and breast (Hynynen et al. 1996) . In addition, therapeutic ultrasound can be used intraductally (Lafon et al. 1999a) , which makes it an approach that is particularly appropriate for carcinoma of the esophageal ducts.
Most interstitial ultrasound applicators use a tubular transducer inducing simultaneous coagulation necrosis of the whole periphery of the applicator (Hynynen et al. 1997) . Sectorbased necroses are generated by remodelling irreversibly a tubular transducer and the radiated acoustic field. The method consists in cutting or paralysing part of the transducer (Diederich et al. 1996a , Nau et al. 1998 . In contrast, a plane transducer generates elementary parallelepiped-shaped lesions in front of the emitting face. As the ultrasonic beam does not diverge in the near field, the pressure drop along the ultrasonic axis is only dependent on the energy attenuation in tissues (Diederich 1996b , Lafon et al. 1999b ).
Each elementary lesion can be induced in less time (10 s), to a greater depth, and with less perfusion-dependence (Billiard et al. 1990 ) than lesions produced by tubular transducers.
The aim of this study was first to conduct ex vivo experiments on pig liver in order to demonstrate the ability of the applicator to generate any angular sector-based shapes of coagulation necroses and to link the depth of the cylindrical lesions with the exposure conditions. In the case of sector-based tumours, both cancerous and thin healthy zones are irradiated. The deposited thermal dose should not induce perforation in the healthy zone, yet it should still coagulate the immediately adjacent cancerous tissues. Consequently, the second aim of this study was to determine the maximal thermal dose that can be delivered to a healthy esophagus without causing perforation. Finally, the thermal dose determined by these in vivo trials was compared with recent studies (Lafon et al. 1999c) to verify whether or not the dose was high enough to necrose malignant cells.
MATERIALS
The active head of the applicator is made of brass and round-shaped to permit transesophageal application without risk of injury (Fig. 1) . The active surface is a 15×8 mm 
METHODS

Ex vivo experiment
These ex vivo tests were conducted on pig liver. Before experiment, each sample of liver was degassed in a vacuum pump (0.7 bars for 30 min) at room temperature to remove bubbles (which can reflect the beam) initially present in the tissue and vessels. During the tests, each sample was immersed in a tank of degassed water maintained at 37°C. A thermocouple was introduced into each sample to ensure that temperature was close to 37°C before commencing the firings. A hole is produced into the center of each sample with a PVC awl (12-mm OD). The ultrasound applicator was introduced into the centre of each parallelepiped-shaped section of liver (100 x 100 x 30 mm 3 ) through the hole (Fig. 2) . 20
shots were done with 18°-increments of angular rotation in order to induce cylindrical zone of coagulation necrosis. The time between the end of one shot and the beginning of the next shot after the rotation is 10 s. These exposure conditions come from our experience in the treatment of biliary cancers (Prat at al. 1999) . This method provides a homogeneous necrosis across the complete circumference. The duration of the elementary exposures was set to 5, 10, 15, and 20 s and the acoustic intensity to 12, 14, and 16 W/cm². A set of three experiments was carried out for each combination of exposure duration and acoustic intensity to ensure reproducibility of the results. A total of 36 circular lesions were created.
Identical exposure conditions were chosen to induce sector-based lesions but the number of increments depended of the treated angle. The acoustic intensity in this case was fixed at 14 W/cm² for 10 s, with the same length of pause between shots. The sectors of necrosis chosen were 72, 108, 198, and 216°. A total of 12 sector-based lesions were produced. The coagulation necroses were inspected macroscopically.
The distinction between the surrounding non-treated tissues can clearly be seen in a medium like pig liver; the lesion has an off-white colour, sometimes dark at the most heated points, similar to that of cooked liver. Liver samples were frozen just after treatment to make the lesion easier to cut and examine. When the tissue temperature was close to -6°C, the tissues were sliced along a plane perpendicular to the applicator rotation axis situated at midheight from the transducer. The depth of the lesion was measured only for circular-type lesions. To account for the fact that the depth is not constant around the whole circumference, the measurements taken along two orthogonal axes in the cutting plane were averaged (Fig.   3 ). Two axes issuing from the centre of the applicator and touching the outer edges of the lesion allowed the value of the angular section of each sector-based lesion.
In vivo trials
In vivo trials were carried out on five healthy pig esophaguses. Male pigs with an average weight of 30 kg were used for the study. Anaesthesia was obtained with a mixture of 4 ml of ketamine (50 mg/ml) and 6 ml of 2% xylazine, administered intramuscularly behind 
RESULTS
Ex vivo results
Thirty-six circular lesions and twelve sector-based lesions were created. The dimension of the lesions along the applicator axis corresponded to the height of the transducer i.e. 15 mm. Cuts perpendicular to the axis of the applicator (Fig. 3) allowed measurement of the radius of the coagulation necrosis volumes, which represents the maximal lesion depth along the acoustic propagation axis. This cross-section demonstrates that the therapeutic depth is constant around the applicator. Figure 3 shows a typical lesion induced by a series of 20 ultrasound shots at an acoustic intensity of 12 W/cm² for 10 s. The average value of the treatment depth, with standard deviation, is given in fig. 4 as a function of intensity and exposure duration (12, 14, and 16 W/cm² for 5, 10, 15, and 20 s). Cylindrical 13 mm-deep lesions can be induced applying 16 W/cm² for 20 s. Figure 5 shows sector-based lesions.
These results were obtained by rotating the transducer over angles of 72, 108, 198 and 216° respectively. The correspondence between the desired angle and the experimental result is given in table 1. The most significant deviation was measured at ±9°. Table 2 summarises the results obtained on the pig esophaguses and proposes a synthesis of the influence of exposure parameters. The effects of the different firing parameters on the healthy esophagus were examined according to the homogeneity of the thermal damage, the treatment of a circular area, the presence or absence of perforation and the proper functioning of the cooling circuit. These experiments show ( Fig. 6 and 9 ) that it is possible to deliver thermal doses that do not prevent healing of healthy exposed tissues. On can be safety delivered to the part of the esophagus adjacent to the trachea was found to be 10 s at 12 W/cm² for circular-type lesions. For this shot sequence, the depths of ex vivo thermal damage were 5±1 mm and 4±1 mm in the esophagus. This latter value is close to the thickness of the esophagus and was determined by histological analysis. In the other parts of the esophagus, the maximum safety thermal dose was found to be 10 s at 14 W/cm² for circular-type lesions. This dose is known to be sufficient to induce the necrosis of tumor tissue (Prat 1999) . This shot sequence is associated with the recovery of healthy tissue. The safety of this HIU treatment was confirmed by histological analysis. It was proved (Fig. 8) that the underlying muscle layers were intact. Figure 8 also shown that, as it was observed for all the firing sequences, mucosal layers are necrosed. Figure 9 shown the very well defined boundary between healthy and necrosed cells.
In vivo results
DISCUSSION
Ex vivo experiments have shown that the 360° lesions induced are circular in shape when the applicator is rotated through an angle of 360°. Moreover, the height of the zone of necrosis is close to that of the transducer, as was reported previously (Lafon 1998b ). The depths of lesions are reproducible with a standard deviation of less than 10 %. Lesional tissue was clearly distinguishable from untreated tissue with the border even perceptible at the macroscopic level. A relationship was established between the radius of the cylindrical lesion and the parameters of sonication (intensity and shot duration). The greatest depths which we were able to generate were 8, 10 and 13 mm for surface intensity levels of 12, 14, and 16 W/cm 2 respectively, all with a sonication time of 20 s. Beyond 20 s, the depth of the lesion does not increase very much because thereafter, the rate at which the heat is being delivered is close to the rate of thermal diffusion. For this reason, it is preferable to choose a sonication time in the shallow region of the curve, which describes the variation of lesion radius as a function of shot parameters. It is also important to bear in mind that increasing the sonication time tends to render the lesion more susceptible to the effect of blood flow.
Furthermore, these ex vivo experiments show that mechanical rotation of the applicator makes it possible to induce coagulation necrosis with a well-defined angle. The difference between the angle chosen and the angle experimentally obtained was no greater than ±9° meaning that sector-based tumors can be treated accurately. The round shape at the edge of the lesion and the difference between the planed treatment angle and the observed result can be explained, firstly by small angular losses during the mechanical rotation of the applicator, and secondly by thermal diffusion, i.e. the heat delivered beyond the treatment margin. The constancy of the reflected power shows that the flow rate of 0.21 liters per minute provides adequate transducer cooling, which is confirmed by the fact that the tissue near to the transducer was not vaporized. An even higher flow rate would cool the superficial layer of the tissue being treated and increase penetration.
A series of in vivo experiments were performed to assess the effects of different thermal doses delivered to healthy esophageal tissue. The specific effects depended on the region of the esophagus being treated. Tracheal tissue contains extensive cartilage and has a far higher attenuation coefficient than does esophageal tissue. In consequence, coagulation necrosis is induced by smaller doses in this area, a phenomenon which can lead to a lifethreatening situation if the organ is perforated. A thermal dose of 12 W/cm 2 for 10 s for circular-type lesions does not cause perforation in either the esophagus or the trachea and allows regeneration of healthy tissue yet it is known to induce necrosis in tumor tissue (Lafon 1999) . For this shot sequence, the depth of ex vivo and in vivo thermal damages are close together because the sonication times are so short that blood flow is only a minor factor when it comes to lesion formation. Other parts of the esophagus can tolerate much higher thermal doses (10 s at 14 W/cm 2 for circular-type lesions) because other neighboring tissues do not attenuate as efficiently as the trachea. All these experiments were conducted on healthy tissue.
For the treatment of tumors, an acoustic intensity of 12 W/cm² will be used for esophageal tissue near the trachea, and one of 14 W/cm² will be used for other parts of the esophagus.
Sonication times will be chosen on the basis of the dimensions of the tumor being treated. The in vivo short-term study has determined, by the way of histological studies, the maximal thermal dose, which never induce a perforation in healthy esophagus. As the underlying muscle layers were intact, the probability that at long term a perforation will appear in the esophagus is very low. Moreover, Chen et al. 1999 clearly shown in a long-term study (4 months) a regeneration of tissues if an underlying structure was intact after a high intensity focused ultrasound treatment.
According to these satisfactory results, the present method could be used for the curative ablation of superficial tumors in high-surgical risk patients as well as for palliation in patients with advanced disease in combination with radio-and chemotherapy, or in patients with tumor recurrence after successful chemoradiotherapy 
